Patents Assigned to Rib-X Pharmaceuticals, Inc.
-
Publication number: 20140094463Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.Type: ApplicationFiled: November 1, 2011Publication date: April 3, 2014Applicant: RIB-X PHARMACEUTICALS, INC.Inventors: Eric S. Burak, Danping Li, David S. Dresback
-
Publication number: 20140088164Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.Type: ApplicationFiled: November 21, 2011Publication date: March 27, 2014Applicant: Rib-X Pharmaceuticals, Inc.Inventor: Danping Li
-
Publication number: 20140088031Abstract: The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.Type: ApplicationFiled: August 21, 2013Publication date: March 27, 2014Applicant: RIB-X PHARMACEUTICALS, INC.Inventors: Ashoke Bhattacharjee, Zoltan F. Kanyo, Edward C. Sherer
-
Publication number: 20140073624Abstract: The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety that are useful as such agents.Type: ApplicationFiled: February 19, 2013Publication date: March 13, 2014Applicant: RIB-X PHARMACEUTICALS, INC.Inventor: Rib-X Pharmaceuticals, Inc.
-
Publication number: 20140051592Abstract: The invention provides a high resolution three-dimensional structure of a deacylated transfer RNA protein synthesis modulator in association with a large ribosomal subunit. The protein synthesis modulator binds at least a portion of the E-site of a large ribosomal subunit. The invention provides methods for designing and/or identifying analogs of candidate molecules, for example, analogs or derivatives of the protein synthesis modulator, that bind and/or modulate the protein biosynthetic activity of the ribosome.Type: ApplicationFiled: March 15, 2013Publication date: February 20, 2014Applicant: RIB-X PHARMACEUTICALS, INC.Inventor: RIB-X PHARMACEUTICALS, INC.
-
Publication number: 20140031402Abstract: The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.Type: ApplicationFiled: March 18, 2013Publication date: January 30, 2014Applicant: RIB-X PHARMACEUTICALS, INC.Inventors: Shili Chen, Rongliang Lou, Yusheng Wu, Jiacheng Zhou, Roger Hanselmann
-
Publication number: 20130344562Abstract: The invention provides a high resolution three-dimensional structure of cycloheximide, either alone or in association with a large ribosomal subunit. The invention provides methods for designing and/or identifying cycloheximide analogs and derivatives that bind and/or modulate the protein biosynthetic activity of the ribosome.Type: ApplicationFiled: February 11, 2013Publication date: December 26, 2013Applicant: RIB-X PHARMACEUTICALS, INC.Inventor: Brian T. Wimberly
-
Patent number: 8497378Abstract: The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.Type: GrantFiled: September 23, 2009Date of Patent: July 30, 2013Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Roger Hanselmann, Maxwell M. Reeve, Graham Johnson
-
Patent number: 8470985Abstract: The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, antiproliferative, anti-inflammatory, and prokinetic agents. These compounds are represented by the following formula (I): wherein R1, R2, ect. Are defined in claim 1.Type: GrantFiled: August 24, 2006Date of Patent: June 25, 2013Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Ashoke Bhattacharjee, Zoltan F. Kanyo
-
Patent number: 8470990Abstract: The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.Type: GrantFiled: December 23, 2009Date of Patent: June 25, 2013Assignees: Rib-X Pharmaceuticals, Inc., Yale UniversityInventors: Thomas A. Steitz, Peter B. Moore, Joyce A. Sutcliffe, Adegboyega K. Oyelere, Joseph A. Ippolito
-
Patent number: 8428884Abstract: The invention provides a high resolution three-dimensional structure of a deacylated transfer RNA protein synthesis modulator in association with a large ribosomal subunit. The protein synthesis modulator binds at least a portion of the E-site of a large ribosomal subunit. The invention provides methods for designing and/or identifying analogs of candidate molecules, for example, analogs or derivatives of the protein synthesis modulator, that bind and/or modulate the protein biosynthetic activity of the ribosome.Type: GrantFiled: February 29, 2008Date of Patent: April 23, 2013Assignee: Rib-X Pharmaceuticals, Inc.Inventor: Brian T. Wimberly
-
Publication number: 20130090326Abstract: The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals.Type: ApplicationFiled: October 15, 2010Publication date: April 11, 2013Applicant: Rib-X Pharmaceuticals, Inc.Inventors: Erin M. Duffy, Ashoke Bhattacharjee, Hardwin O'Dowd, Marco DeVivo, Yanming Du, Sandra Sinishtaj, Yuanqing Tang, Brian T. Wimberly
-
Patent number: 8399660Abstract: The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.Type: GrantFiled: June 8, 2006Date of Patent: March 19, 2013Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Shili Chen, Rongliang Lou, Yusheng Wu, Jiacheng Zhou, Roger Hanselmann
-
Patent number: 8374794Abstract: The invention provides a high resolution three-dimensional structure of cycloheximide, either alone or in association with a large ribosomal subunit. The invention provides methods for designing and/or identifying cycloheximide analogs and derivatives that bind and/or modulate the protein biosynthetic activity of the ribosome.Type: GrantFiled: February 29, 2008Date of Patent: February 12, 2013Assignee: Rib-X Pharmaceuticals, Inc.Inventor: Brian T. Wimberly
-
Patent number: 8324398Abstract: The present invention relates to processes for the preparation of biaryl oxazolidinones. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.Type: GrantFiled: July 28, 2004Date of Patent: December 4, 2012Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Yusheng Wu, Shili Chen, Yi Chen, Roger Hanselmann, Rongliang Lou, Jiacheng Zhou
-
Patent number: 8278281Abstract: The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The compounds have the following structure: wherein T is the macrocyclic part.Type: GrantFiled: August 24, 2006Date of Patent: October 2, 2012Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Ashoke Bhattacharjee, Zoltan F. Kanyo, Edward C. Sherer
-
Publication number: 20120220566Abstract: The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals.Type: ApplicationFiled: October 15, 2010Publication date: August 30, 2012Applicant: Rib-X Pharmaceuticals, Inc.Inventors: Erin M. Duffy, Ashoke Bhattacharjee, Hardwin O'Dowd, Marco DeVivo, Zoltan F. Kanyo, Jacek G. Martinow, Ik-Hyeon Paik, Matthew H. Scheideman, Sandra Sinishtaj, Brian T. Wimberly, Yusheng Wu
-
Publication number: 20120202792Abstract: The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and/or reducing the risk of microbial infections in humans and animals.Type: ApplicationFiled: October 15, 2010Publication date: August 9, 2012Applicant: Rib-X Pharmaceuticals, Inc.Inventors: Erin M. Duffy, Ashoke Bhattacharjee, Hardwin O'Dowd, Shili Chen, Marco DeVivo, Rongliang Lou, Brian T. Wimberly
-
Patent number: 8202843Abstract: The present invention provides macrocyclic compounds useful as therapeutic agents of the formula: or a pharmaceutically acceptable salt, ester, N-oxide, or prodrug thereof, wherein T, R1, R2, R3, D, E, F, and G are as defined herein. More particularly, these compounds are useful as anti-infective, antiproliferative, anti-inflammatory and prokinetic agents.Type: GrantFiled: February 25, 2005Date of Patent: June 19, 2012Assignee: Rib-X Pharmaceuticals, Inc.Inventors: Jay J. Farmer, Ashoke Bhattacharjee, Yi Chen, Joel A. Goldberg, Joseph A. Ippolito, Zoltan F. Kanyo, Rongliang Lou, Adegboyega K. Oyelere, Edward C. Sherer, Joyce A. Sutcliffe, Deping Wang, Yusheng Wu, Yanming Du
-
Publication number: 20120041208Abstract: The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.Type: ApplicationFiled: September 23, 2009Publication date: February 16, 2012Applicant: RIB-X PHARMACEUTICALS, INC.Inventors: Roger Hanselmann, Maxwell M. Reeve, Graham Johnson